SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-07-000129
Filing Date
2007-02-12
Accepted
2007-02-12 15:14:08
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvf-anadys_sc13ga.htm SC 13G/A 102450
  Complete submission text file 0000898432-07-000129.txt   104646
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Subject) CIK: 0001128495 (see all company filings)

IRS No.: 223193172
Type: SC 13G/A | Act: 34 | File No.: 005-79854 | Film No.: 07602545
SIC: 2834 Pharmaceutical Preparations